Table 4 Most common PIMs among older adults with Parkinson’s disease in China, 2015–2017

Central nervous system medications

 Antipsychotics

  Olanzapine^a

543 (3.8)

Yes

Yes

  Risperidone

539 (3.7)

Yes

Yes

  Perphenazine^a

215 (1.5)

Yes

Yes

  Chlorpromazine^a

114 (0.8)

Yes

Yes

  Haloperidol

109 (0.8)

Yes

Yes

  Sulpiride

90 (0.6)

Yes

Yes

 Benzodiazepines

  Eszolam

1126 (7.8)

Yes

  Alprazolam

888 (6.1)

Yes

  Clonazepam

420 (2.9)

Yes

  Diazepam

414 (2.9)

Yes

  Lorazepam

248 (1.7)

Yes

  Oxazepam

94 (0.7)

Yes

 Non-benzodiazepines

  Zolpidem

264 (1.8)

Yes

  Eszopiclone

170 (1.2)

Yes

 Antidepressants

  Flupentixol/Melitracen

794 (5.5)

Yes

Yes

  Sertraline

286 (2.0)

  Escitalopram

225 (1.6)

  Paroxetine^a

215 (1.5)

Yes

  Fluoxetine

104 (0.7)

  Venlafaxine

92 (0.6)

  Citalopram

90 (0.6)

  Mirtazapine

86 (0.6)

 Antiepileptics

  Carbamazepine

87 (0.6)

 Antiemetics

  Metoclopramide

420 (2.9)

Yes

  Promethazine^a

231 (1.6)

Yes

Yes

 Anticholinergics

  Trihexyphenidyl

2386 (16.5)

Yes

Cardiovascular medications

 Diuretics

  Furosemide

1000 (6.9)

Endocrine system medications

 Sulfonylureas, long acting

  Glimepiride

202 (1.4)